481 related articles for article (PubMed ID: 36693907)
1. Targeting protein phosphatases in cancer immunotherapy and autoimmune disorders.
Stanford SM; Bottini N
Nat Rev Drug Discov; 2023 Apr; 22(4):273-294. PubMed ID: 36693907
[TBL] [Abstract][Full Text] [Related]
2. Role of tyrosine phosphatase inhibitors in cancer treatment with emphasis on SH2 domain-containing tyrosine phosphatases (SHPs).
Irandoust M; van den Berg TK; Kaspers GJ; Cloos J
Anticancer Agents Med Chem; 2009 Feb; 9(2):212-20. PubMed ID: 19199865
[TBL] [Abstract][Full Text] [Related]
3. Protein tyrosine phosphatases in autoimmunity.
Vang T; Miletic AV; Arimura Y; Tautz L; Rickert RC; Mustelin T
Annu Rev Immunol; 2008; 26():29-55. PubMed ID: 18303998
[TBL] [Abstract][Full Text] [Related]
4. Protein tyrosine phosphatases as drug targets: strategies and challenges of inhibitor development.
Barr AJ
Future Med Chem; 2010 Oct; 2(10):1563-76. PubMed ID: 21426149
[TBL] [Abstract][Full Text] [Related]
5. Targeting Tyrosine Phosphatases: Time to End the Stigma.
Stanford SM; Bottini N
Trends Pharmacol Sci; 2017 Jun; 38(6):524-540. PubMed ID: 28412041
[TBL] [Abstract][Full Text] [Related]
6. Are other protein tyrosine phosphatases than PTPN22 associated with autoimmunity?
Mustelin T
Semin Immunol; 2006 Aug; 18(4):254-60. PubMed ID: 16678435
[TBL] [Abstract][Full Text] [Related]
7. Targeting Protein Tyrosine Phosphatases to Improve Cancer Immunotherapies.
Salmond RJ
Cells; 2024 Jan; 13(3):. PubMed ID: 38334623
[TBL] [Abstract][Full Text] [Related]
8. The therapeutic potential of phosphatase inhibitors.
Vintonyak VV; Antonchick AP; Rauh D; Waldmann H
Curr Opin Chem Biol; 2009 Jun; 13(3):272-83. PubMed ID: 19410499
[TBL] [Abstract][Full Text] [Related]
9. Protein tyrosine phosphatases: mechanisms of catalysis and regulation.
Denu JM; Dixon JE
Curr Opin Chem Biol; 1998 Oct; 2(5):633-41. PubMed ID: 9818190
[TBL] [Abstract][Full Text] [Related]
10. Protein tyrosine phosphatases as potential therapeutic targets.
He RJ; Yu ZH; Zhang RY; Zhang ZY
Acta Pharmacol Sin; 2014 Oct; 35(10):1227-46. PubMed ID: 25220640
[TBL] [Abstract][Full Text] [Related]
11. Characterization of hematopoietic intracellular protein tyrosine phosphatases: description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences.
Matthews RJ; Bowne DB; Flores E; Thomas ML
Mol Cell Biol; 1992 May; 12(5):2396-405. PubMed ID: 1373816
[TBL] [Abstract][Full Text] [Related]
12. Targeting protein serine/threonine phosphatases for drug development.
McConnell JL; Wadzinski BE
Mol Pharmacol; 2009 Jun; 75(6):1249-61. PubMed ID: 19299564
[TBL] [Abstract][Full Text] [Related]
13. Targeting phosphatases: From molecule design to clinical trials.
Guo M; Li Z; Gu M; Gu J; You Q; Wang L
Eur J Med Chem; 2024 Jan; 264():116031. PubMed ID: 38101039
[TBL] [Abstract][Full Text] [Related]
14. Protein Tyrosine Phosphatases in Systemic Sclerosis: Potential Pathogenic Players and Therapeutic Targets.
Sacchetti C; Bottini N
Curr Rheumatol Rep; 2017 May; 19(5):28. PubMed ID: 28397126
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Targeting of Oncogenic Tyrosine Phosphatases.
Frankson R; Yu ZH; Bai Y; Li Q; Zhang RY; Zhang ZY
Cancer Res; 2017 Nov; 77(21):5701-5705. PubMed ID: 28855209
[TBL] [Abstract][Full Text] [Related]
16. Drugging the Undruggable: Therapeutic Potential of Targeting Protein Tyrosine Phosphatases.
Zhang ZY
Acc Chem Res; 2017 Jan; 50(1):122-129. PubMed ID: 27977138
[TBL] [Abstract][Full Text] [Related]
17. Challenges and opportunities in the development of protein phosphatase-directed therapeutics.
De Munter S; Köhn M; Bollen M
ACS Chem Biol; 2013 Jan; 8(1):36-45. PubMed ID: 23214403
[TBL] [Abstract][Full Text] [Related]
18. Protein phosphatase-2A regulates protein tyrosine phosphatase activity in Lewis lung carcinoma tumor variants.
Jackson JL; Young MR
Clin Exp Metastasis; 2003; 20(4):357-64. PubMed ID: 12856723
[TBL] [Abstract][Full Text] [Related]
19. Allosteric Modulation of Phosphatase Activity May Redefine Therapeutic Value.
Salamoun JM; Wipf P
J Med Chem; 2016 Sep; 59(17):7771-2. PubMed ID: 27539118
[TBL] [Abstract][Full Text] [Related]
20. Targeting phosphatases of regenerating liver (PRLs) in cancer.
Wei M; Korotkov KV; Blackburn JS
Pharmacol Ther; 2018 Oct; 190():128-138. PubMed ID: 29859177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
